(Total Views: 476)
Posted On: 07/08/2024 1:10:19 PM
Post# of 154058
Quote:
Ohm, your regulator list shows that LL downregulates PI3K. Is there any new information in the article that would be applicable to LL, e.g., possible additions to your disease list?
Most of them related to vascular leakage are already on the disease list - kidney disease, heart disease, stroke, sepsis and Covid. The two ones that aren't are possibly retinopathy and ARDS but ARDS is also a byproduct of Covid and where leronlimab is of most use.
(5)
(0)
